Dyne Therapeutics, Inc. (DYN)
14.24
-1.05
(-6.87%)
USD |
NASDAQ |
Oct 16, 16:00
14.24
0.00 (0.00%)
After-Hours: 18:48
Dyne Therapeutics Net Income (TTM) : -519.41M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -519.41M |
| March 31, 2026 | -451.71M |
| December 31, 2025 | -446.21M |
| September 30, 2025 | -423.80M |
| June 30, 2025 | -412.88M |
| March 31, 2025 | -367.13M |
| December 31, 2024 | -317.42M |
| September 30, 2024 | -294.51M |
| June 30, 2024 | -257.60M |
| March 31, 2024 | -257.40M |
| December 31, 2023 | -235.94M |
| September 30, 2023 | -208.13M |
| Date | Value |
|---|---|
| June 30, 2023 | -189.30M |
| March 31, 2023 | -176.70M |
| December 31, 2022 | -168.10M |
| September 30, 2022 | -181.06M |
| June 30, 2022 | -182.26M |
| March 31, 2022 | -159.91M |
| December 31, 2021 | -149.29M |
| September 30, 2021 | -126.15M |
| June 30, 2021 | -97.49M |
| March 31, 2021 | -72.94M |
| December 31, 2020 | -53.84M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | -266.10M |
| Neurocrine Biosciences, Inc. | 705.50M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 8.743B |
| Anika Therapeutics, Inc. | -3.121M |